Bisphosphonate-related osteonecrosis: Laser-assisted surgical treatment or conventional surgery?

Lasers in Medical Science

Volumn 26, Issue 6, 2011, Pages 815-823

  Atalay, Belir ^a   Yalcin, Serhat ^a   Emes, Yusuf ^a   Aktas, Irem ^b   Aybar, Buket ^a   Issever, Halim ^c   Mandel, Nil Molinas ^a   Cetin, Ozge ^a   Oncu, Bora ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b Medical Park Private Bahçelievler Hospital   (Turkey)

^c ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Bisphosphonates; Cancer; Conventional bone curettage; Laser surgery; Osteonecrosis; Serum terminal C telopeptide

Indexed keywords

CARBOXY TERMINAL TELOPEPTIDE; ZOLEDRONIC ACID;

ADULT; AGED; ARTICLE; AVASCULAR NECROSIS; BISPHOSPHONATE RELATED OSTEONECROSIS OF JAW; BONE TURNOVER; BREAST CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE CLASSIFICATION; DRUG INDUCED DISEASE; ERBIUM YAG LASER; FEMALE; HEALING; HUMAN; INTERMETHOD COMPARISON; JAW OSTEONECROSIS; LASER SURGERY; LOW LEVEL LASER THERAPY; LUNG CANCER; MALE; NEODYMIUM LASER; ORAL SURGERY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROTEIN BLOOD LEVEL; TREATMENT OUTCOME;

ADULT; AGED; BISPHOSPHONATE-ASSOCIATED OSTEONECROSIS OF THE JAW; BONE DENSITY CONSERVATION AGENTS; BREAST NEOPLASMS; COLLAGEN TYPE I; DIPHOSPHONATES; FEMALE; HUMANS; IMIDAZOLES; LASER THERAPY, LOW-LEVEL; LASERS, SOLID-STATE; LUNG NEOPLASMS; MALE; MIDDLE AGED; PEPTIDES; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES;

EID: 83255185211     PISSN: 02688921     EISSN: 1435604X     Source Type: Journal    
DOI: 10.1007/s10103-011-0974-2     Document Type: Article

References (49)

1. Advisory Task Force On Bisphosphonates Related Osteonecrosis of the Jaws, American Association of Oral and Maxillofacial Surgeons (2007) American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg 65:369-376. doi:10.1016/j.joms.2006.11.003 (Pubitemid 46329248)
2. Kan B, Altay MA, Taşar F, Akova M (2010) Low-level laser therapy supported teeth extractions of two patients receiving IV zolendronate. Lasers Med Sci. doi:10.1007/s10103-010-0816-7, [Epub ahead of print
3. American Dental Association Council on Scientific Affairs (2006) Dental management of patients receiving oral bisphosphonates therapy. J Am Dent Assoc 137:1144-1150
4. Badros A, Weikel D, Salama A, Goloubeva O, Schneider A, Rapoport A, Fenton R, Gahres N, Sausville E, Ord R, Meiller T (2006) Osteonecrosis of the jaw in multiple myeloma patients: clinical features and risk factors. J Clin Oncol 24:945-952 (Pubitemid 46638849)
5. Boonyapakorn T, Schirmer I, Reichart PA, Sturm I, Massenkeil G (2008) Bisphosphonate-induced osteonecrosis of the jaws: prospective study of 80 patients with multiple myeloma and other malignancies. Oral Oncol 44:857-869
6. Marx RE, Sawatari Y, Fortin M, Broumand V (2005) Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment. J Oral Maxillofac Surg 63:1567-1575 (Pubitemid 41525412)
7. Migliorati CA, Schubert MM, Peterson DE, Seneda LM (2005) Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy. Cancer 104:83-93 (Pubitemid 40847755)
8. Ruggiero SL, Mehrotra B, Rosenberg TJ, Engroff SL (2004) Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac Surg 62:527-534 (Pubitemid 38542516)
9. Woo SB, Hellstein JW, Kalmar JR (2006) Narrative [corrected] review: bisphosphonates and osteonecrosis of the jaws. Ann Intern Med 144:753-761 (Pubitemid 46780635)
10. Greenberg MS (2004) Intravenous bisphosphonates and osteonecrosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 98:259-260 (Pubitemid 39200690)
11. Marx RE (2003) Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 61:1115-1117 (Pubitemid 37064711)
12. Mücke T, Haarmann S, Wolff KD, Hölzle F (2009) Bisphosphonate related osteonecrosis of the jaws treated by surgical resection and immediate osseous microvascular reconstruction. J Craniomaxillofac Surg 37:291-297
13. Vogel F, Scholz H, al-Nawas B, Elies W, Kresken M, Lode H, Muller O, Naber KG, Petersen E, Shah P, Sorgel F, Stille W, Tauchnitz C, Trautmann M, Ullmann U, Wacha H, Wiedemann B (2002) Rational use of oral antibiotics. Findings of an expert commission of the Paul Ehrlich Society for Chemotherapy. Med Monatsschr Pharm 25:193
14. Hibst R (1992) Mechanical effects of erbium:YAG laser bone ablation. Lasers Surg Med 12:125-130
15. Scoletta M, Arduino PG, Reggio L, Dalmasso P, Mozzati M (2010) Effect of low-level laser irradiation on bisphosphonateinduced osteonecrosis of the jaws: preliminary results of a prospective study. Photomed Laser Surg 28:179-184
16. Gál P, Mokrý M, Vidinský B, Kilík R, Depta F, Harakalová M, Longauer F, Mozes S, Sabo J (2009) Effect of equal daily doses achieved by different power densities of low-level laser therapy at 635 nm on open skin wound healing in normal and corticosteroidtreated rats. Lasers Med Sci 24:539-547
17. Gál P, Vidinský B, Toporcer T, Mokrý M, Mozes S, Longauer F, Sabo J (2006) Histological assessment of the effect of laser irradiation on skin wound healing in rats. Photomed Laser Surg 24:480-488 (Pubitemid 44689865)
18. Ozcelik O, Cenk Haytac M, Kunin A, Seydaoglu G (2008) Improved wound healing by low-level laser irradiation after gingivectomy operations: a controlled clinical pilot study. J Clin Periodontol 35:250-254
19. Amorim JC, de Sousa GR, de Barros SL, Prates RA, Pinotti M, Ribeiro MS (2006) Clinical study of the gingiva healing after gingivectomy and low-level laser therapy. Photomed Laser Surg 24:588-594 (Pubitemid 44736328)
20. Markovic A, Lj T (2007) Effectiveness of dexamethasone and low-power laser in minimizing oedema after third molar surgery: a clinical trial. Int J Oral Maxillofac Surg 36:226-229 (Pubitemid 46201534)
21. Antunes HS, de Azevedo AM, da Silva Bouzas LF, Adão CA, Pinheiro CT, Mayhe R, Pinheiro LH, Azevedo R, D'Aiuto de Matos V, Rodrigues PC, Small IA, Zangaro RA, Ferreira CG (2007) Low-power laser in the prevention of induced oral mucositis in bone marrow transplantation patients: a randomized trial. Blood 109:2250-2255 (Pubitemid 46348230)
22. Pinheiro AL, Martinez Gerbi ME, de Assis Limeira F Jr, Carneiro Ponzi EA, Marques AM, Carvalho CM, de Carneiro Santos R, Oliveira PC, Nóia M, Ramalho LM (2009) Bone repair following bone grafting hydroxyapatite guided bone regeneration and infra- red laser photobiomodulation: a histological study in a rodent model. Lasers Med Sci 24(2):234-240, Epub 2008 Apr 17
23. Pinheiro AL, Limeira Júnior Fde A, Gerbi ME, Ramalho LM, Marzola C, Ponzi EA (2003) Effect of low-level laser therapy on the repair of bone defects grafted with inorganic bovine bone. Braz Dent J 14(3):177-181, Epub 2004 Mar 29
24. Vescovi P, Merigo E, Manfredi M, Meleti M, Fornaini C, Bonanini M, Rocca JP, Nammour S (2008) Nd:YAG laser biostimulation in the treatment of bisphosphonate-associated osteonecrosis of the jaw: clinical experience in 28 cases. Photomed Laser Surg 26:37-46 (Pubitemid 351206155)
25. Rosen HN, Moses AC, Garber J, Iloputaife ID, Ross DS, Lee SL, Greenspan SL (2000) Serum CTX. A new marker of bone resorption that shows treatment effect more often than other markers because of low coefficient of variability and large changes with bisphosphonate therapy. Calcif Tissue Int 66:100-103 (Pubitemid 30056702)
26. Marx RE, Cillo JE Jr, Ulloa JJ (2007) Oral bisphosphonate induced osteonecrosis: risk factors, prediction of risk using serum CTX testing prevention and treatment. J Oral Maxillofac Surg 65:2397-2410 (Pubitemid 350100982)
27. Ruggiero SL (2011) Bisphosphonate-related osteonecrosis of the jaw: an overview. Ann NY Acad Sci 1218:38-46. doi:10.1111/ j.1749-6632.2010.05768.x, Epub 2010 Sep 28
28. Badros A, Terpos E, Katodritou E, Goloubeva O, Kastriris E, Verrou E, Zervas K, Baer MR, Meiller T, Dimopoulos M.A. (2008) Natural history of osteonecrosis of the jaw in patients with multiple myeloma. J Clin Oncol 26:5904-5909
29. Montebugnoli I, Felicetti L, Gissi DB, Pizzigallo A, Pelliccioni GA, Marchetti C (2007) Bisphoshonate-associated osteonecrosis can be controlled by nonsurgical management. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 104:473-477
30. Filleul O, Crompot E, Saussez S (2010) Bisphoshonate-induced osteonecrosis of the jaw: a review of 2,400 patient cases. J Cancer Res Clin Oncol 136:1117-1124
31. Van den Wyngaert T, Claeys T, Huizing MT, Vermorken JB, Fossion E (2009) Initial experience with conservative treatment in cancer patients with osteonecrosis of the jaw (ONJ) and predictors of outcome. Ann Oncol 20:331-336
32. Vescovi P, Merigo E, Meleti M, Fornaini C, Nammour S, Manfredi M (2007) Nd:YAG laser biostimulation of bisphosphonateassociated necrosis of the jawbone with and without surgical treatment. Br J Oral Maxillofac Surg 45:628-632 (Pubitemid 350048599)
33. Angiero F, Sannino C, Borloni R, Crippa R, Benedicenti S, Romanos GE (2009) Osteonecrosis of the jaws caused by bisphosphonates: evaluation of a new therapeutic approach using the Er:YAG laser. Lasers Med Sci 24:849-856
34. Aleksic V, Aoki A, Iwasaki K, Takasaki AA, Wang CY, Abiko Y, Ishikawa I, Izumi Y (2010) Low-level Er:YAG laser irradiation enhances osteoblast proliferation through activation of MAPK/ ERK. Lasers Med Sci 25:559-569
35. Aoki A, Sasaki KM, Watanabe H, Ishikawa I (2004) Lasers in nonsurgical periodontal therapy. Periodontol 36:59-97 (Pubitemid 41699685)
36. Schwarz F, Bieling K, Bonsmann M, Latz T, Becker J (2006) Nonsurgical treatment of moderate and advanced periimplantitis lesions: a controlled clinical study. Clin Oral Invest 10:279-288 (Pubitemid 44835039)
37. Schwarz F, Aoki A, Becker J, Sculean A (2008) Laser application in non-surgical periodontal therapy: a systematic review. J Clin Periodontol 35:29-44
38. Leucht P, Lam K, Kim JB, Mackanos MA, Simanovskii DM, Longaker MT, Contag CH, Schwettman HA, Helms JA (2007) Accelerated bone repair after plasma laser corticotomies. Ann Surg 246:140-150 (Pubitemid 47012219)
39. Stübinger S, Von Rechenberg B, Zeilhofer HF, Sader R, Landes C (2007) Er:YAG laser osteotomy for removal of impacted teeth: clinical comparison of two techniques. Lasers SurgMed 39:583-588 (Pubitemid 47502866)
40. Kujawa J, Zavodnik L, Zavodnik I, Buko V, Lapshyna A, Bryszewska M (2004) Effect of low-intensity (3.75-25 J/cm2) near-infrared (810 nm) laser radiation on red blood cell ATPase activities and membrane structure. J Clin Laser Med Surg 22 (2):111-117 (Pubitemid 38679925)
41. Tuner J, Hode L (2007) The Laser Therapy Handbook. Prima Books AB, Sweden, pp 317-338
42. Dimopoulos MA, Kastritis E, Bamia C, Melakopoulos I, Gika D, Roussou M, Migkou M, Eleftherakis-Papaiakovou E, Christoulas D, Terpos E, Bamias A (2009) Reduction of osteonecrosis of the jaw (ONJ) after implementation of preventive measures in patients with multiple myeloma treated with zoledronic acid. Ann Oncol 20:117-120
43. Corso A, Varettoni M, Zappasodi P, Klersy C, Mangiacavalli S, Pica G, Lazzarino M (2007) A different schedule of zoledronic acid can reduce the risk of the osteonecrosis of the jaw in patients with multiple myeloma. Leukemia 21:1545-1548 (Pubitemid 46965296)
44. Mawardi H, Treister N, Richardson P, Anderson K, Munshi N, Faiella RA, Woo SB (2009) Sinus tracts- an early sign of bisphosphonate-associated osteonecrosis of the jaws? J Oral Maxillofac Surg 67:593-601
45. Engroff SL, Kim DD (2007) Treating bisphosphonate osteonecrosis of the jaws: is there a role for resection and vascularized reconstruction? J Oral Maxillofac Surg 65:2374-2385 (Pubitemid 47588586)
46. Khosla S, Burr D, Cauley J, Dempster DW, Ebeling PR, Felsenberg D, Gagel RF, Gilsanz V, Guise T, Koka S, McCauley LK, McGowan J, McKee MD, Mohla S, Pendrys DG, Raisz LG, Ruggiero SL, Shafer DM, Shum L, Silverman SL, Van Poznak CH, Watts N, Woo SB, Shane E, A Society for Bone and Mineral Research (2007) Bisphosphonate- associated osteonecrosis of the jaw: report of a task force of American Society for Bon and Mineral Research. J Bone Miner Res 22:1479-1491 (Pubitemid 351229318)
47. Pautke C, Bauer F, Bissinger O, Tischer T, Kreutzer K, Steiner T, Weitz J, Otto S, Wolff KD, Stürzenbaum SR, Kolk A (2010) Tetracycline bone fluorescence: a valuable marker for osteonecrosis characterization and therapy. J Oral Maxillofac Surg 68:125-129
48. Pautke C, Bauer F, Otto S, Tischer T, Steiner T, Weitz J, Kreutzer K, Hohlweg-Majert B, Wolff KD, Hafner S, Mast G, Ehrenfeld M, Stürzenbaum SR, Kolk A (2011) Fluorescence-guided bone resection in bisphosphonate-related osteonecrosis of the jaws: first clinical results of a prospective pilot study. J Oral Maxillofac Surg 69:84-91
49. Pautke C, Bauer F, Tischer T, Kreutzer K, Weitz J, Kesting M, Hölzle F, Kolk A, Stürzenbaum SR, Wolff KD (2009) Fluorescence-guided bone resection in bisphosphonate-associated osteonecrosis of the jaws. J Oral Maxillofac Surg 67:471-476